Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eiger Biopharma
(NQ:
EIGR
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 10, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eiger Biopharma
< Previous
1
2
3
4
5
Next >
Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Notifies Eiger BioPharmaceuticals, Inc. (EIGR) Investors of Class Action and Encourages Investors to Actively Participate
November 16, 2022
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
November 16, 2022
From
Law Offices of Howard G. Smith
Via
Business Wire
The Law Offices of Frank R. Cruz Announces Investigation of Eiger BioPharmaceuticals, Inc. (EIGR) on Behalf of Investors
November 15, 2022
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Eiger BioPharma Shuns Plans For FDA Emergency Use Nod For COVID-19 Treatment
October 05, 2022
Via
Benzinga
FDA Might Need New Data From Eiger Bio's COVID-19 Treatment Prospect
September 06, 2022
Via
Benzinga
EMA's Advisory Committee Recommends Eiger's Zokinvy In Premature Aging Disorder
May 20, 2022
Via
Benzinga
EIGER ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Eiger Biopharmaceuticals, Inc. and Encourages Investors to Contact the Firm
November 14, 2022
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
ROSEN, A TOP RANKED FIRM, Encourages Eiger BioPharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - EIGR
November 13, 2022
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Eiger Biopharmaceutials, Inc. (EIGR)
November 09, 2022
From
Robbins LLP
Via
Business Wire
NASDAQ:EIGR Investor Notice Investigation Announced over Potential Wrongdoing at Eiger BioPharmaceuticals, Inc.
November 09, 2022
San Diego, CA -- (SBWIRE) -- 11/09/2022 -- Certain directors of Eiger BioPharmaceuticals, Inc are under investigation over potential breaches of fiduciary duties.
Via
SBWire
EQUITY ALERT: Rosen Law Firm Encourages Eiger BioPharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EIGR
November 09, 2022
From
The Rosen Law Firm, P.A.
Via
Business Wire
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
November 09, 2022
From
The Schall Law Firm
Via
Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Eiger BioPharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm
November 08, 2022
From
The Schall Law Firm
Via
Business Wire
11 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 05, 2022
Gainers Bionano Genomics (NASDAQ:BNGO) stock increased by 9.8% to $2.24. The company's market cap stands at $649.9 million.
Via
Benzinga
NASDAQ:EIGR Investor Notice: Investigation over Possible Securities Laws Violations by Eiger BioPharmaceuticals, Inc.
September 21, 2022
San Diego, CA -- (SBWIRE) -- 09/21/2022 -- Eiger BioPharmaceuticals, Inc is under investigation concerning potential securities laws violations in connection with certain financial statements.
Via
SBWire
Starbucks To $94? Here Are 5 Other Price Target Changes For Wednesday
September 07, 2022
Citigroup raised the price target on Starbucks Corporation (NASDAQ: SBUX) from $90 to $94. Citigroup analyst Jon Tower maintained a Neutral rating on the stock. Starbucks shares fell 0.1% to $84.50 in...
Via
Benzinga
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
September 07, 2022
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
Via
Benzinga
Dow Tumbles Over 200 Points; ChannelAdvisor Shares Spike Higher
September 06, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 06, 2022
Via
Benzinga
Nasdaq Drops 100 Points; DWAC Shares Plummet
September 06, 2022
U.S. stocks traded lower midway through trading, with the Nasdaq dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around...
Via
Benzinga
Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday
September 06, 2022
Via
Benzinga
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
September 06, 2022
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist...
Via
Benzinga
US Stocks Trade Lower; Dow Drops Over 100 points
September 06, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Tuesday. All the three major indices recorded their third weekly loss in a row, with the Dow dropping around 3%,...
Via
Benzinga
Eiger BioPharmaceuticals Earnings Perspective: Return On Capital Employed
August 24, 2022
According to Benzinga Pro data, during Q2, Eiger BioPharmaceuticals (NASDAQ:EIGR) posted sales of $4.09 million. Earnings were up 3.35%, but Eiger BioPharmaceuticals still reported an overall loss of...
Via
Benzinga
Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate
August 04, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
July 20, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data
June 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: Veru Shares Up On COVID Candidate Update, FDA Approves Lilly's COVID Treatment, Latest On Sanofi-AstraZeneca RSV Vaccine
May 11, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
64 Biggest Movers From Yesterday
March 18, 2022
Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...
Via
Benzinga
31 Stocks Moving In Thursday's Mid-Day Session
March 17, 2022
Gainers TD Holdings, Inc. (NASDAQ: GLG) rose 83.2% to $0.4348 after the company reported FY21 results. Allego N.V. (NASDAQ: ALLG) shares gained 45.5% to $9.40. Spartan...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.